Neural Expression of IL-16 Mediates Neuropathic Pain after Sciatic Injury in Mice.
5 affiliations
- 1Farmacología, Facultad de Medicina, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, C/Julián Clavería 6, Oviedo, Asturias, 33006, Spain.
- 2Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
- 3Departamento de Radiología, Complejo Asistencial Universitario de León, León, Spain.
- 4Farmacología, Facultad de Medicina, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, C/Julián Clavería 6, Oviedo, Asturias, 33006, Spain. [email protected].
- 5Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain. [email protected].
Abstract
The neutralization of interleukin-16 (IL-16) or of its main target, CD4 receptors, as well as the reduction of its synthesis by inhibiting caspase-3 have been recently considered as possible strategies to inhibit pain. Here we study the involvement of peripheral mechanisms related to the IL-16/CD4 axis in the nociceptive responses evoked after ligation of sciatic nerve in mice. Systemic administration of anti-IL-16 or anti-CD4 antibodies inhibited hyperalgesia and allodynia measured 2 days after ligation in male and female mice. In addition, both antibodies were also analgesic 9 days after nerve ligation, supporting the participation of IL-16 and CD4 in the establishment and maintenance of neuropathic pain. Following nerve injury, Il16 expression remained unaltered in dorsal root ganglia (DRGs) and damaged nerves, whereas Casp3 expression increased in DRGs and the enzymatic activity of caspase-3 was enhanced in damaged nerves. Immunofluorescence assays demonstrated a limited presence of IL-16 in DRG neurons, that remained unmodified after injury, and a clear up-regulation of this cytokine in injured nerves. Double immunofluorescence assays with βIII-tubulin and S100β antibodies demonstrated that IL-16 is expressed both in axons and Schwann cells after nerve ligation. The ability of IL-16 to evoke nociception by directly acting on nerves was confirmed by intra-sciatic administration. Immunofluorescence labelling of CD4 receptors was also present in injured nerves, being also up-regulated both in axons and Schwann cells. Finally, hyperalgesia and allodynia were prevented by the intra-sciatic administration of anti-IL-16 or anti-CD4 antibodies, thus supporting the relevance of the IL-16/CD4 axis in neuropathic hypernociception.
Related
- Effects of Piracetam and Hyperbaric Oxygen on Histopathological and Circulating Biochemical Responses Following Sciatic Nerve Crush Injury in Rats
- Real-world device survival, revision burden and observed pain patterns after epidural spinal cord stimulation for neuropathic pain in adults with spinal cord injury: protocol for a longitudinal observational cohort study using routine clinical data
- Ovariectomy Exacerbates Chronic Constriction Injury-Induced Neuropathic Pain Through Dysregulation of Spinal Estrogen Receptor Balance in Rats
- Long-term use of opioids and neuropathic medication after diaphyseal humerus fractures with or without nerve injury: a nationwide register-based cohort study of 4,185 patients.
- Notch signaling pathway mediates anti-inflammatory effects of vagus nerve stimulation during lipopolysaccharide-induced acute kidney injury
BibTeX
@article{coromartin2026neural,
title = {{Neural Expression of IL-16 Mediates Neuropathic Pain after Sciatic Injury in Mice.}},
author = {Alba Coro-Martín and Alejandro Álvarez-Artime and Sara González-Rodríguez and María González-Amor and David Corral-Fontecha and Ana Baamonde and Luis Menéndez},
journal = {Molecular neurobiology},
year = {2026},
month = oct,
doi = {10.1007/s12035-026-06280-2},
url = {https://europepmc.org/article/MED/42911322},
note = {CC BY},
}
RIS
TY - JOUR
TI - Neural Expression of IL-16 Mediates Neuropathic Pain after Sciatic Injury in Mice.
AU - Alba Coro-Martín
AU - Alejandro Álvarez-Artime
AU - Sara González-Rodríguez
AU - María González-Amor
AU - David Corral-Fontecha
AU - Ana Baamonde
AU - Luis Menéndez
PY - 2026
DA - 2026/10/22
JO - Molecular neurobiology
DO - 10.1007/s12035-026-06280-2
UR - https://europepmc.org/article/MED/42911322
AB - The neutralization of interleukin-16 (IL-16) or of its main target, CD4 receptors, as well as the reduction of its synthesis by inhibiting caspase-3 have been recently considered as possible strategies to inhibit pain. Here we study the involvement of peripheral mechanisms related to the IL-16/CD4 axis in the nociceptive responses evoked after ligation of sciatic nerve in mice. Systemic administration of anti-IL-16 or anti-CD4 antibodies inhibited hyperalgesia and allodynia measured 2 days after ligation in male and female mice. In addition, both antibodies were also analgesic 9 days after nerve ligation, supporting the participation of IL-16 and CD4 in the establishment and maintenance of neuropathic pain. Following nerve injury, Il16 expression remained unaltered in dorsal root ganglia (DRGs) and damaged nerves, whereas Casp3 expression increased in DRGs and the enzymatic activity of caspase-3 was enhanced in damaged nerves. Immunofluorescence assays demonstrated a limited presence of IL-16 in DRG neurons, that remained unmodified after injury, and a clear up-regulation of this cytokine in injured nerves. Double immunofluorescence assays with βIII-tubulin and S100β antibodies demonstrated that IL-16 is expressed both in axons and Schwann cells after nerve ligation. The ability of IL-16 to evoke nociception by directly acting on nerves was confirmed by intra-sciatic administration. Immunofluorescence labelling of CD4 receptors was also present in injured nerves, being also up-regulated both in axons and Schwann cells. Finally, hyperalgesia and allodynia were prevented by the intra-sciatic administration of anti-IL-16 or anti-CD4 antibodies, thus supporting the relevance of the IL-16/CD4 axis in neuropathic hypernociception.
SN - 0893-7648
SN - 1559-1182
ER -